Key Takeaways
- TSLA shares began trading Tuesday at $330.88, marking a 26% decline year-to-date
- Second-quarter earnings per share reached $0.33, falling short of the $0.50 forecast, while revenue hit $28.24B, exceeding projections by approximately $2B
- Federal safety regulators issued a recall affecting 20,349 Model 3 and Model Y units due to headlight intensity concerns
- Wall Street maintains a “Hold” consensus with analysts projecting an average target of $401.74
- Generali Investments reduced its TSLA holdings by 23.2% during Q2, while major institutional investors like Vanguard and State Street preserved substantial positions
Shares of Tesla commenced Tuesday’s session at $330.88, registering a modest 0.1% gain in premarket activity. The electric vehicle manufacturer’s stock has fallen 26% since the start of the year, remaining significantly beneath its 52-week peak of $498.83.
Technical indicators show the 50-day moving average positioned at $377.06, while the 200-day average rests at $392.83—both considerably higher than the current trading level. The company maintains a market capitalization of $1.31 trillion.
Tesla’s second-quarter financial results, released on July 22, presented a mixed picture. The automaker posted $28.24 billion in revenue, representing a 25.5% year-over-year increase and surpassing the $26.42 billion forecast.
However, earnings per share landed at $0.33, substantially below the $0.50 consensus estimate. This disappointing bottom-line performance has applied downward pressure on shares throughout the summer months.
The company’s price-to-earnings ratio currently stands at 306, a valuation metric that concerns even optimistic investors. The price-to-earnings-growth ratio measures 16.59, while analysts project full-year EPS of $0.88 on average.
Wall Street Outlook and Target Prices
Analyst sentiment remains divided. Among the 45 analysts monitored by MarketBeat, 21 recommend a Buy rating, 19 suggest Hold, and four advise Sell. One analyst maintains a Strong Buy recommendation.
The consensus price target sits at $401.74, representing approximately 21% upside from current trading levels. Truist and Barclays both maintain $370 targets alongside Hold or Equal Weight stances. The most pessimistic outlook comes from Phillip Securities at $215.
Two upcoming developments could facilitate a stock recovery. Wednesday’s consumer price index data, if it comes in below expectations, might strengthen arguments for the Federal Reserve to maintain current interest rates, benefiting growth-oriented stocks like Tesla.
Progress in artificial intelligence initiatives could also provide momentum. While Tesla continues significant investments in robotaxi development, Optimus humanoid robotics, and proprietary semiconductor technology, shareholders are still awaiting tangible financial returns.
Institutional Investment Trends
Generali Investments decreased its position by 23.2% during the second quarter, divesting 11,717 shares while maintaining 38,814 units valued at approximately $16.3 million. Tesla represents the firm’s eighth-largest holding, comprising 3.5% of its portfolio.
Vanguard, holding the largest institutional position, expanded its stake by 2.6% in the fourth quarter, accumulating over 258 million shares. State Street and Geode Capital similarly increased their holdings.
Individual investors have also been accumulating shares. Recent data suggests approximately $372 million in retail capital flowed into Tesla positions, driven by long-term confidence in the company’s AI and autonomous vehicle ambitions.
Regarding product developments, Tesla submitted applications for a $10.1 billion solar-cell manufacturing facility in Texas. Additionally, a six-passenger Model Y configuration contributed to the company’s best July sales results in Australia.
Tuesday brought news of an NHTSA recall covering 20,349 Model 3 and Model Y vehicles due to low-beam headlights exceeding brightness regulations. The announcement produced minimal reaction in the stock’s trading pattern.
Chief Financial Officer Vaibhav Taneja divested 3,000 shares on May 13 at $450 per share, generating proceeds of $1.35 million. The transaction was executed to satisfy tax obligations on vested equity compensation. Company insiders collectively control 19.90% of outstanding shares.





